HIGHLIGHTS
- who: Sadahisa Ogasawara and collaborators from the Department of Gastroenterology and Nephrology, Graduate School of Medicine, University, Japan have published the research: Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0161303]. August 18, 2016 of August/18,/2016
- what: The aims of this study were as follows: to characterize and assess sorafenib-treated patients focusing on stage progressing processes from initial diagnosis prior to sorafenib therapy and_(2) to compare data of patients diagnosed in intermediate-stage HCC on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.